Phase 2 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 to 80 years old who have been diagnosed with early breast cancer confirmed by a laboratory tissue test.
- People who have not yet received any cancer treatment and are planning to start chemotherapy before surgery (called neoadjuvant chemotherapy).
- People who have mild anxiety, as measured by a score of 50 on a standard anxiety questionnaire called the Self-Rating Anxiety Scale.
- People who are reasonably physically active and able to carry out basic daily activities, and who are expected to live for at least 3 more months (confirm with trial site).
- People who have at least one area of cancer that can be measured on a scan, taken within 2 weeks before joining the trial.
- People whose blood test results show the bone marrow is producing enough blood cells, meeting specific minimum levels for white blood cells, neutrophils, and platelets (confirm with trial site for exact values).
- People whose liver, kidney, and heart are functioning at an acceptable level, based on blood tests and a heart scan showing specific results within set limits (confirm with trial site for exact values).
- People who are able to understand what the study involves, are willing to take part, and have signed a consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who cannot receive aromatherapy because they are allergic to aromatherapy materials or have a condition affecting their sense of smell.
- People who have had surgery within the 2 weeks before joining the trial.
- People who have had a serious heart or brain event in the past 12 months, such as unstable chest pain, a heart attack, bleeding in the brain, or a stroke (a minor type of stroke with no symptoms that needs no treatment may be an exception — confirm with trial site).
- People who have had an active autoimmune disease requiring treatment, such as steroid or immune-suppressing medications, in the past 2 years (people taking steroids only to replace hormones due to a specific adrenal condition are also excluded — confirm with trial site).
- People who have a confirmed history or current diagnosis of a neurological or mental health condition, including epilepsy or dementia.
- People who the research team considers unsuitable for any other reason, including other health conditions or circumstances that could interfere with the study or affect their safety.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianli J Zhao, doctorate, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phone: 15920589334
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in anxiety score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.